1. KMT2A‐MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8‐year follow‐up. Issue 1 (22nd September 2021) Authors: Felix, Carolyn A.; Slater, Diana J.; Davenport, James W.; Yu, Xiang; Gregory, Brian D.; Li, Marilyn M.; Rappaport, Eric F.; Cheung, Nai‐Kong V. Journal: Pediatric blood & cancer Issue: Volume 69:Issue 1(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗